PRS:抽脂等塑形手术中如何避免大出血?且看这份血液管理策略!

2021-04-21 MedSci原创 MedSci原创

急性贫血是整形外科中非常常见的并发症,发病率和死亡率很高。输血也被认为是一种并发症,最强的诱发风险因素是术前贫血。

急性贫血是整形外科中非常常见的并发症,发病率和死亡率很高。输血也被认为是一种并发症,最强的诱发风险因素是术前贫血。 患者血液管理是一系列术前、术中, 以及手术后的措施和策略,其目的是在手术前诊断和治疗贫血,从而使手术期间的失血最小化以维持血红蛋白水平。 在美容手术中,尚没有标准化的过程来最大限度地减少手术中的出血。为此,一项研究旨在实施患者血液管理策略,以减少接受人体轮廓手术的患者的出血和输血。 该研究从2017年1月至2018年5月,进行了一项前瞻性队列型观察研究,包括两组接受单一或联合身体塑形手术的患者。 第一组没有接受患者血液管理策略,而第二组接受了这些策略。这些措施包括术前策略,以确保患者具有最佳的血红蛋白和红细胞压积水平,以及术中支持措施,以最大限度地减少失血。根据所研究的变量,用不同的统计检验来验证结果。 该研究共纳入409名患者,并分为两组。两组的人体测量和血红蛋白变量相似。 实施患者血液管理策略的207名患者在72小时内平均比未实施患者血液管理策略的202名患者减少1.2 g/dl血红蛋白(p ≤ 0.0001)。 图1。术后血红蛋白水平根据管理接收。PBM,病人血液管

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1966963, encodeId=cc7919669632a, content=<a href='/topic/show?id=b5bde60540a' target=_blank style='color:#2F92EE;'>#管理策略#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76054, encryptionId=b5bde60540a, topicName=管理策略)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Fri Aug 06 07:32:24 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669073, encodeId=0a7616690e3e2, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Sun May 02 20:32:24 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316183, encodeId=63cb131618301, content=<a href='/topic/show?id=7a1c4360e6e' target=_blank style='color:#2F92EE;'>#大出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43607, encryptionId=7a1c4360e6e, topicName=大出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Fri Apr 23 11:32:24 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443263, encodeId=98821443263b8, content=<a href='/topic/show?id=b4ec893251f' target=_blank style='color:#2F92EE;'>#血液管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89325, encryptionId=b4ec893251f, topicName=血液管理)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0015042838, createdName=ms6279672939590805, createdTime=Fri Apr 23 11:32:24 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2021-08-06 gous
  2. [GetPortalCommentsPageByObjectIdResponse(id=1966963, encodeId=cc7919669632a, content=<a href='/topic/show?id=b5bde60540a' target=_blank style='color:#2F92EE;'>#管理策略#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76054, encryptionId=b5bde60540a, topicName=管理策略)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Fri Aug 06 07:32:24 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669073, encodeId=0a7616690e3e2, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Sun May 02 20:32:24 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316183, encodeId=63cb131618301, content=<a href='/topic/show?id=7a1c4360e6e' target=_blank style='color:#2F92EE;'>#大出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43607, encryptionId=7a1c4360e6e, topicName=大出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Fri Apr 23 11:32:24 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443263, encodeId=98821443263b8, content=<a href='/topic/show?id=b4ec893251f' target=_blank style='color:#2F92EE;'>#血液管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89325, encryptionId=b4ec893251f, topicName=血液管理)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0015042838, createdName=ms6279672939590805, createdTime=Fri Apr 23 11:32:24 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2021-05-02 kzlchina
  3. [GetPortalCommentsPageByObjectIdResponse(id=1966963, encodeId=cc7919669632a, content=<a href='/topic/show?id=b5bde60540a' target=_blank style='color:#2F92EE;'>#管理策略#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76054, encryptionId=b5bde60540a, topicName=管理策略)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Fri Aug 06 07:32:24 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669073, encodeId=0a7616690e3e2, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Sun May 02 20:32:24 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316183, encodeId=63cb131618301, content=<a href='/topic/show?id=7a1c4360e6e' target=_blank style='color:#2F92EE;'>#大出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43607, encryptionId=7a1c4360e6e, topicName=大出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Fri Apr 23 11:32:24 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443263, encodeId=98821443263b8, content=<a href='/topic/show?id=b4ec893251f' target=_blank style='color:#2F92EE;'>#血液管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89325, encryptionId=b4ec893251f, topicName=血液管理)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0015042838, createdName=ms6279672939590805, createdTime=Fri Apr 23 11:32:24 CST 2021, time=2021-04-23, status=1, ipAttribution=)]
    2021-04-23 cmsvly
  4. [GetPortalCommentsPageByObjectIdResponse(id=1966963, encodeId=cc7919669632a, content=<a href='/topic/show?id=b5bde60540a' target=_blank style='color:#2F92EE;'>#管理策略#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76054, encryptionId=b5bde60540a, topicName=管理策略)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Fri Aug 06 07:32:24 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669073, encodeId=0a7616690e3e2, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Sun May 02 20:32:24 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316183, encodeId=63cb131618301, content=<a href='/topic/show?id=7a1c4360e6e' target=_blank style='color:#2F92EE;'>#大出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43607, encryptionId=7a1c4360e6e, topicName=大出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Fri Apr 23 11:32:24 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443263, encodeId=98821443263b8, content=<a href='/topic/show?id=b4ec893251f' target=_blank style='color:#2F92EE;'>#血液管理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89325, encryptionId=b4ec893251f, topicName=血液管理)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0015042838, createdName=ms6279672939590805, createdTime=Fri Apr 23 11:32:24 CST 2021, time=2021-04-23, status=1, ipAttribution=)]

相关资讯

成都女子称抽脂手术后大腿麻木肿胀 美容机构:不能证明系手术引发

12月3日,成都市民余女士再次来到成都熹亚婕熹卡(下简称“熹亚美容”)医疗美容门诊部进行协商,但双方未能达成一致。 今年5月3日,余女士在熹亚美容做了一次大腿抽脂和面部整形手术,通过按揭贷款,共付款22800元。余女士称,术后她的左大腿出现了麻木、肿胀、积液和疼痛,“我认为是熹亚美容所做抽脂手术所导致的,要求医院退款,承担后续治疗费用。”3日中午,熹亚美容一位负责运营的陈经理回应封面新闻

拓展阅读

是认真的吗?抽脂后成了这副鬼模样,还瞎了……

今天我们学习一例罕见的腹部和大腿抽脂术后单侧失明和多发性皮肤坏死的病例,该手术采用清创术和植皮治疗。

Aesthetic Plast Surg:通过抽脂术重建乳房下皱褶:重建乳房美学必要技术

乳房下皱褶(IMF)是乳房重要的美学组成部分,它限制了乳房的下缘,并决定了乳房下垂的程度,本文描述了患者在不同的乳房手术(主要是乳房切除后重建)中重建和确定IMF的技术,并介绍了所取得的长期结果。

10 年回顾性研究:多阶段吸脂术后患者报告的脂肪水肿相关症状改善

尽管外科手术治疗脂肪水肿的需求越来越大,但抽脂术的证据仍然有限。关于疾病分期、患者年龄、体重指数或现有共病对临床结果的影响知之甚少。

多中心研究显示,这项TULUA腹部抽脂术效果美观,安全又可靠!

TULUA(横向折叠,无破坏性,完全吸脂,新脐成形术和腹部下横向瘢痕)是一种完全不同的腹部脂肪成形术的首字母缩写,旨在增加简单性,提高血管安全性,并获得良好效果。

快速安全又有效,不用抽脂也能拥有六块腹肌的午间整形术式!

虽说腹部抽脂可以增强肌肉轮廓,但抽脂是有创术式,本文分享了一种无创溶脂术式,并评估了这种术式的安全性和有效性。

JAAD:连续3430例不同浓度利多卡因肿胀局麻吸脂效果观察

抽脂术是全世界最常见的整形外科手术之一。肿胀局部麻醉(TLA)技术的引入使手术过程发生了革命性的变化,使用400 mg/L的利多卡因生理盐水对大部分身体区域提供足够的麻醉.